Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00867685 · ClinicalTrials.gov registry record · Phase 1
Phase I 2-Way Crossover Study to Assess Relative BA of Tablet Versus Liquid Suspension and Food Effect on Tablet Formulation
A Phase 1 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT00867685 is a Phase 1 study that has completed, run by AstraZeneca. The registered enrollment target is 16 participants.
The verdict
NCT00867685, a Phase 1 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the liquid suspension form of AZD 2624 to a tablet form of the same drug. This study will also study the effect of food on the tablet form of the drug.
Interventions
- DRUG AZD2624
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2009-03 |
| Est. Completion | 2009-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00867685
The ClinicalTrials.gov registry entry for NCT00867685 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AZD2624 is the first listed.
NCT00867685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00867685 about?
NCT00867685 is a clinical study titled "Phase I 2-Way Crossover Study to Assess Relative BA of Tablet Versus Liquid Suspension and Food Effect on Tablet Formulation". The purpose of this study is to compare the liquid suspension form of AZD 2624 to a tablet form of the same drug. This study will also study the effect of food on the tablet form of the drug.
What is the current status of trial NCT00867685?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2009-03. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00867685?
The interventions under investigation include: AZD2624 (DRUG).
Who is sponsoring clinical trial NCT00867685?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.